FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Ahern

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Scott W Graf; P Hakendorf; Sue Lester; Karen Patterson; Malcolm D Smith; Jennifer G Walker; Michael J Ahern; Peter J Roberts-Thomson
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
P Hissaria; S Lester; P Hakendorf; R Woodman; K Patterson; C Hill; Michael J Ahern; Malcolm D Smith; Jennifer G Walker; Peter J Roberts-Thomson
Survival in scleroderma: results from the population-based South Australian Register.
M Dugar; V Limaye; Leslie G Cleland; Michael J Ahern
Fibrodysplasia ossificans progressiva presenting as ankylosing spondylitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Ahern (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Scott W Graf; P Hakendorf; Sue Lester; Karen Patterson; Malcolm D Smith; Jennifer G Walker; Michael J Ahern; Peter J Roberts-Thomson
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
International journal of rheumatic diseases 2012;15(1):102-9.
2011: P Hissaria; S Lester; P Hakendorf; R Woodman; K Patterson; C Hill; Michael J Ahern; Malcolm D Smith; Jennifer G Walker; Peter J Roberts-Thomson
Survival in scleroderma: results from the population-based South Australian Register.
Internal medicine journal 2011;41(5):381-90.
2010: M Dugar; V Limaye; Leslie G Cleland; Michael J Ahern
Fibrodysplasia ossificans progressiva presenting as ankylosing spondylitis.
Internal medicine journal 2010;40(12):862-4.
2010: E Michael Shanahan; I Lindemann; Michael J Ahern
Engaging medical students in occupational and environmental medicine--a new approach.
Occupational medicine (Oxford, England) 2010;60(7):566-8.
2010: Malcolm D Smith; Helen Weedon; Virginia Papangelis; Jennifer Walker; Peter J Roberts-Thomson; Michael J Ahern
Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.
Rheumatology (Oxford, England) 2010;49(5):862-75.
2009: Anak A S S K Dharmapatni; Malcolm D Smith; David M Findlay; Christopher A Holding; Andreas Evdokiou; Michael J Ahern; Helen Weedon; Paul Chen; Gavin Screaton; Xiao N Xu; David R Haynes
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.
Arthritis research & therapy 2009;11(1):R13.
2008: Michael J Ahern; D G Campbell; Helen Weedon; V Papangelis; Malcolm D Smith
Effect of intra-articular infliximab on synovial membrane pathology in a patient with a seronegative spondyloarthropathy.
Annals of the rheumatic diseases 2008;67(9):1339-42.
2008: E Michael Shanahan; M D Smith; L Roberts-Thomson; Adrian Esterman; Michael J Ahern
The effect of rheumatoid arthritis on personal income in Australia.
Internal medicine journal 2008;38(7):575-9.
2007: Jennifer G Walker; Michael J Ahern; Mark Coleman; Helen Weedon; V Papangelis; Dimitra Beroukas; Peter J Roberts-Thomson; MD Smith
Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(8):992-9.
2006: Jennifer G Walker; Michael J Ahern; Mark Coleman; Helen Weedon; V Papangelis; Dimitra Beroukas; Peter J Roberts-Thomson; MD Smith
Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment.
Annals of the rheumatic diseases 2006;65(12):1558-64.
2006: Peter J Roberts-Thomson; Jennifer G Walker; T Y-T Lu; Adrian Esterman; P Hakendorf; Malcolm D Smith; Michael J Ahern
Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.
Internal medicine journal 2006;36(8):489-97.
2006: A J Roberts-Thomson; N Massy-Westropp; M D Smith; Michael J Ahern; John Highton; Peter J Roberts-Thomson
The use of the hand anatomic index to assess deformity and impaired function in systemic sclerosis.
Rheumatology international 2006;26(5):439-44.
2006: Jennifer G Walker; Michael J Ahern; Mark Coleman; Helen Weedon; V Papangelis; Dimitra Beroukas; Peter J Roberts-Thomson; MD Smith
Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(2):149-56.
2005: Jennifer G Walker; John Stirling; Dimitra Beroukas; Kencana Dharmapatni; David R Haynes; Malcolm D Smith; Michael J Ahern; Peter J Roberts-Thomson
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis.
Pathology 2005;37(3):220-5.
2005: J Zurauskas; Dimitra Beroukas; Jennifer G Walker; Malcolm D Smith; Michael J Ahern; Peter J Roberts-Thomson
Scleroderma in Australian aborigines.
Internal medicine journal 2005;35(1):60-2.
2005: SR Cox; Jennifer G Walker; Mark Coleman; Maureen Rischmueller; Susanna M Proudman; Malcolm D Smith; Michael J Ahern; Peter J Roberts-Thomson
Isolated pulmonary hypertension in scleroderma.
Internal medicine journal 2005;35(1):28-33.
2004: E Michael Shanahan; Malcolm D Smith; M Wetherall; C W Lott; John P Slavotinek; Oliver FitzGerald; Michael J Ahern
Suprascapular nerve block in chronic shoulder pain: are the radiologists better?
Annals of the rheumatic diseases 2004;63(9):1035-40.
2004: Peter J Roberts-Thomson; D A Male; Jennifer G Walker; SR Cox; X Shen; Malcolm D Smith; Michael J Ahern; D R Turner
Genomic instability in scleroderma.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2004;22(2-3):153-8.
2004: Maarten C Kraan; Jasper J Haringman; Helen Weedon; EC Barg; Malcolm D Smith; Michael J Ahern; Tom J M Smeets; Ferdinand C Breedveld; Paul P Tak
T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.
Annals of the rheumatic diseases 2004;63(5):483-8.
2004: Tania N Crotti; Malcolm D Smith; David M Findlay; Hala Zreiqat; Michael J Ahern; Helen Weedon; G Hatzinikolous; Maria Capone; Christopher A Holding; David R Haynes
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
Biomaterials 2004;25(4):565-73.
2003: Malcolm D Smith; M Wetherall; T Darby; Adrian Esterman; John P Slavotinek; Peter J Roberts-Thomson; Mark Coleman; Michael J Ahern
A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee.
Rheumatology (Oxford, England) 2003;42(12):1477-85.
2003: Tania N Crotti; Michael J Ahern; Kylie Lange; Helen Weedon; Mark Coleman; Peter J Roberts-Thomson; David R Haynes; Malcolm D Smith
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis.
The Journal of rheumatology 2003;30(11):2319-24.
2003: Tania N Crotti; Malcolm D Smith; Robert Hirsch; Steven Soukoulis; Helen Weedon; Maria Capone; Michael J Ahern; David Haynes
Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
Journal of periodontal research 2003;38(4):380-7.
2003: Jennifer G Walker; Michael J Ahern; Malcolm D Smith; Mark Coleman; Kevin D Pile; Maureen Rischmueller; Leslie G Cleland; Peter J Roberts-Thomson
Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
Internal medicine journal 2003;33(5-6):216-20.
2003: Malcolm D Smith; EC Barg; Helen Weedon; V Papengelis; Tom J M Smeets; Paul P Tak; Maarten C Kraan; Mark Coleman; Michael J Ahern
Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints.
Annals of the rheumatic diseases 2003;62(4):303-7.
2003: David R Haynes; EC Barg; Tania N Crotti; Christopher A Holding; Helen Weedon; Gerald J Atkins; A Zannetino; Michael J Ahern; Mark Coleman; Peter J Roberts-Thomson; Maarten C Kraan; Paul P Tak; Malcolm D Smith
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.
Rheumatology (Oxford, England) 2003;42(1):123-34.
2003: Amel Katrib; Malcolm D Smith; Michael J Ahern; John P Slavotinek; Leanne Stafford; Carolyn Cuello; James V Bertouch; H Patrick McNeil; Peter P Youssef
Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
The Journal of rheumatology 2003;30(1):10-21.
2002: Peter J Roberts-Thomson; Michael E Jones; Jennifer G Walker; James G Macfarlane; Malcolm D Smith; Michael J Ahern
Stochastic processes in the causation of rheumatic disease.
The Journal of rheumatology 2002;29(12):2628-34.
2002: Tania N Crotti; Malcolm D Smith; Helen Weedon; Michael J Ahern; David M Findlay; Maarten C Kraan; Paul P Tak; David R Haynes
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis.
Annals of the rheumatic diseases 2002;61(12):1047-54.
2002: Peter J Roberts-Thomson; Jennifer G Walker; P Hakendorf; M D Smith; Michael J Ahern
Microchimerism in systemic sclerosis: comment on the article by Johnson et al.
Arthritis and rheumatism 2002;46(9):2538; author reply 2538-9.
2002: E Michael Shanahan; Michael J Ahern; Malcolm D Smith
Which patients stop working because of RA?
Annals of the rheumatic diseases 2002;61(9):859; author reply 859.
2002: Fiona Goldblatt; W Hill; Michael J Ahern; Malcolm D Smith
Shortness of breath in systemic lupus erythematosus: a diagnostic and therapeutic dilemma.
Annals of the rheumatic diseases 2002;61(7):588-90.
2002: Malcolm D Smith; Jennifer G Walker; David Schultz; Julie Ash; Peter J Roberts-Thomson; E Michael Shanahan; Michael J Ahern
Teaching clinical skills in musculoskeletal medicine: the use of structured clinical instruction modules.
The Journal of rheumatology 2002;29(4):813-7.
2002: Peter J Robert-Thomson; Tiffany L Mould; Jennifer G Walker; Malcolm D Smith; Michael J Ahern
Clinical utility of telangiectasia of hands in scleroderma and other rheumatic disorders.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2002;20(1):7-12.
2001: A A Dharmapatni; M D Smith; Michael J Ahern; A Simpson; C Li; S Kumar; Peter J Roberts-Thomson
The TGF beta receptor endoglin in systemic sclerosis.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2001;19(4):275-82.
2001: P K Wong; Carolyn Cuello; James V Bertouch; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith; Peter P Youssef
Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1alpha in rheumatoid synovium.
The Journal of rheumatology 2001;28(12):2634-6.
2001: Malcolm D Smith; W Ross; Michael J Ahern
Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
The Journal of rheumatology 2001;28(11):2504-8.
2001: Malcolm D Smith; John P Slavotinek; V Au; Helen Weedon; A Parker; Mark Coleman; Peter J Roberts-Thomson; Michael J Ahern
Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
Rheumatology (Oxford, England) 2001;40(9):965-77.
2001: Peter J Roberts-Thomson; M Jones; P Hakendorf; A A Kencana Dharmapatni; Jennifer G Walker; J G MacFarlane; Malcolm D Smith; Michael J Ahern
Scleroderma in South Australia: epidemiological observations of possible pathogenic significance.
Internal medicine journal 2001;31(4):220-9.
2001: Malcolm D Smith; Maarten C Kraan; John P Slavotinek; V Au; Helen Weedon; A Parker; Mark Coleman; Peter J Roberts-Thomson; Michael J Ahern
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies.
Rheumatology (Oxford, England) 2001;40(4):367-74.
2001: Malcolm D Smith; S P Cheah; K Taylor; Michael J Ahern
Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
The Journal of rheumatology 2001;28(3):566-70.
2001: Maarten C Kraan; Malcolm D Smith; Helen Weedon; Michael J Ahern; Ferdinand C Breedveld; Paul P Tak
Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis.
Annals of the rheumatic diseases 2001;60(3):296-8.
2001: L Young; Amel Katrib; Carolyn Cuello; U Vollmer-Conna; James V Bertouch; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith; Peter P Youssef
Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study.
Arthritis and rheumatism 2001;44(2):343-50.
2001: M D Smith; Michael J Ahern; Peter J Roberts-Thomson; Peter P Youssef
Similar effects of pulse corticosteroid and tumor necrosis factor alpha blockade in rheumatoid arthritis: comment on the article by Taylor et al.
Arthritis and rheumatism 2001;44(1):245-6.
2001: Maarten C Kraan; Dhavalkumar D Patel; Jasper J Haringman; Malcolm D Smith; Helen Weedon; Michael J Ahern; Ferdinand C Breedveld; Paul P Tak
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8).
Arthritis research 2001;3(1):65-71.
2000: M D Smith; Peter J Roberts-Thomson; Michael J Ahern
The role of intravenous methylprednisolone pulses in the management of rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(11):1296-7.
2000: P Wong; Carolyn Cuello; James V Bertouch; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith; Peter P Youssef
The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(10):1067-73.
2000: Malcolm D Smith; S Henry-Edwards; E Michael Shanahan; Michael J Ahern
Evaluation of patient partners in the teaching of the musculoskeletal examination.
The Journal of rheumatology 2000;27(6):1533-7.
2000: Maarten C Kraan; Jasper J Haringman; Michael J Ahern; Ferdinand C Breedveld; Malcolm D Smith; Paul P Tak
Quantification of the cell infiltrate in synovial tissue by digital image analysis.
Rheumatology (Oxford, England) 2000;39(1):43-9.
1999: E Michael Shanahan; Malcolm D Smith; Michael J Ahern
Pulse methylprednisolone therapy for arthritis causing muscle weakness.
Annals of the rheumatic diseases 1999;58(9):521-2.
1999: SC Hedger; Peter J Macardle; Malcolm J Bond; Michael J Ahern; M D Smith; Peter J Roberts-Thomson
Shared rheumatoid epitope as a risk factor in determining outcome in rheumatoid arthritis.
Australian and New Zealand journal of medicine 1999;29(2):234-8.
1999: SC Hedger; R A Geddes; L Wheatland; Peter J Macardle; M D Smith; Michael J Ahern; Peter J Roberts-Thomson
Clinical utility of the flow cytometric technique for shared rheumatoid epitope.
Rheumatology international 1999;19(1-2):31-4.
1998: M D Smith; A Parker; Peter J Roberts-Thomson; Michael J Ahern; M Coleman
[Production of IL-1 and IL-1 RA in different stages of arthritis].
La Revue du praticien 1998;48(17 Suppl):S16-23.
1998: C Bond; Kevin D Pile; J D McNeil; Michael J Ahern; M D Smith; Leslie G Cleland; Peter J Roberts-Thomson
South Australian Scleroderma Register: analysis of deceased patients.
Pathology 1998;30(4):386-90.
1998: R Wikaningrum; John Highton; A Parker; M Coleman; Paul A Hessian; P J Roberts-Thompson; Michael J Ahern; M D Smith
Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient.
Arthritis and rheumatism 1998;41(10):1783-97.
1998: Y Y Ong; Tony Nikoloutsopoulos; C P Bond; Malcolm D Smith; Michael J Ahern; Peter J Roberts-Thomson
Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 1998;16(2-3):81-6.
1998: Michael J Ahern; M D Smith; Peter J Roberts-Thomson
Methotrexate hepatotoxicity: what is the evidence?
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1998;47(4):148-51.
1998: Peter J Roberts-Thomson; M D Smith; Michael J Ahern
Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
Arthritis and rheumatism 1998;41(3):564-5.
1997: Peter P Youssef; S Triantafillou; A Parker; M Coleman; Peter J Roberts-Thomson; Michael J Ahern; M D Smith
Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis.
The Journal of rheumatology 1997;24(12):2291-8.
1997: Peter P Youssef; David R Haynes; S Triantafillou; A Parker; J R Gamble; Peter J Roberts-Thomson; Michael J Ahern; M D Smith
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis.
Arthritis and rheumatism 1997;40(8):1400-8.
1996: Peter P Youssef; S Triantafillou; A Parker; M Coleman; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith
Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression.
Arthritis and rheumatism 1996;39(12):1970-9.
1996: G Chandran; Michael J Ahern; P Seshadri; D Coghlan
Rheumatic manifestations of the myelodysplastic syndromes: a comparative study.
Australian and New Zealand journal of medicine 1996;26(5):683-8.
1996: Peter P Youssef; J Cormack; C A Evill; D T Peter; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith
Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone.
Arthritis and rheumatism 1996;39(2):216-25.
1996: Malcolm D Smith; G Chandran; Peter P Youssef; T Darby; Michael J Ahern
Day case knee arthroscopy under regional anaesthesia, performed by rheumatologists.
Australian and New Zealand journal of medicine 1996;26(1):108-9.
1995: G Chandran; M Smith; Michael J Ahern; Peter J Roberts-Thomson
A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.
Australian and New Zealand journal of medicine 1995;25(6):688-94.
1995: Peter P Youssef; B X Mantzioris; Peter J Roberts-Thomson; Michael J Ahern; Malcolm D Smith
Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils.
Journal of immunological methods 1995;186(2):217-24.
1995: Prue H Hart; Michael J Ahern; Malcolm D Smith; John J Finlay-Jones
Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Immunology 1995;84(4):536-42.
1995: Michael J Ahern; A C McFarlane; A Leslie; J Eden; Peter J Roberts-Thomson
Illness behaviour in patients with arthritis.
Annals of the rheumatic diseases 1995;54(4):245-50.
1995: Prue H Hart; Michael J Ahern; Malcolm D Smith; John J Finlay-Jones
Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Clinical and experimental immunology 1995;99(3):331-7.
1994: John L Plummer; P D Hall; AH Ilsley; P L Cmielewski; Michael J Ahern; R A Williams
Dose-response relationships in hepatic injury produced by alcohol and carbon tetrachloride.
Alcoholism, clinical and experimental research 1994;18(6):1523-6.
1994: P M Hall; John L Plummer; AH Ilsley; Michael J Ahern; P L Cmielewski; R A Williams
The pathology of liver injury induced by the chronic administration of alcohol and 'low-dose' carbon tetrachloride in Porton rats.
Journal of gastroenterology and hepatology 1994;9(3):250-6.
1994: M Heytman; Michael J Ahern; Malcolm D Smith; Peter J Roberts-Thomson
The longterm effect of pulsed corticosteroids on the efficacy and toxicity of chrysotherapy in rheumatoid arthritis.
The Journal of rheumatology 1994;21(3):435-41.
1993: Prue H Hart; Michael J Ahern; C A Jones; K L Jones; Malcolm D Smith; John J Finlay-Jones
Synovial fluid macrophages and blood monocytes differ in their response to IL-4.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3370-80.
1993: P J Hayball; Roger L Nation; F Bochner; Lloyd Sansom; Michael J Ahern; M D Smith
The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.
British journal of clinical pharmacology 1993;36(3):185-93.
1993: M Crotty; Michael J Ahern; Alexander C McFarlane; Peter M Brooks
Clinical rheumatology training of Australian medical students. A national survey of 1991 graduates.
The Medical journal of Australia 1993;158(2):119-20.
1992: P J Hayball; D G Cosh; Michael J Ahern; D W Schultz; P J Roberts-Thomson
High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response.
European journal of clinical pharmacology 1992;42(1):85-8.
1992: Peter J Roberts-Thomson; M Rischmueller; R A Kwiatek; M Soden; Michael J Ahern; W R Hill; R A Geddes
Rheumatic manifestations of infective endocarditis.
Rheumatology international 1992;12(2):61-3.
1992: Michael J Ahern; M Wetherall; A Leslie; R H James; P J Roberts-Thomson; G C Rennie
A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis.
The British journal of clinical practice 1992;46(4):229-33.
1991: Michael J Ahern; W Harrison; P Hollingsworth; J Bradley; B Laing; C Bayliss
A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis.
Australian and New Zealand journal of medicine 1991;21(6):844-9.
1991: P D Hall; Michael J Ahern; L R Jarvis; P Stoll; M A Jenner; H Harley
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1991;50(7):471-6.
1991: Michael J Ahern; S Kevat; W Hill; P J Hayball; H Harley; P D Hall
Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.
Annals of the rheumatic diseases 1991;50(7):477-80.
1991: Michael J Ahern; M Soden; D Schultz; M Clark
The musculo-skeletal examination: a neglected clinical skill.
Australian and New Zealand journal of medicine 1991;21(3):303-6.
1990: T R Southwood; Peter J Roberts-Thomson; Michael J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.
Annals of the rheumatic diseases 1990;49(12):968-72.
1990: C S Wong; G Champion; Malcolm D Smith; M Soden; M Wetherall; R A Geddes; W R Hill; Michael J Ahern; Peter J Roberts-Thomson
Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study.
Annals of the rheumatic diseases 1990;49(6):370-2.
1990: Malcolm D Smith; Michael J Ahern; Peter J Roberts-Thomson
Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?
Annals of the rheumatic diseases 1990;49(4):265-7.
1990: Michael J Ahern; P J Roberts-Thomson; J Bradley; C Story; P Seshadri
Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.
Annals of the rheumatic diseases 1990;49(2):103-6.
1989: Malcolm D Smith; A Smith; J O'Donnell; Michael J Ahern; Peter J Roberts-Thomson
Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy.
Annals of the rheumatic diseases 1989;48(2):108-13.
1988: Peter J Roberts-Thomson; K Shepherd; T R Southwood; Michael J Ahern; L Y Koh; J O'Donnell; J Ziegler; J Edmonds
Low molecular weight IgM in juvenile chronic arthritis.
Archives of disease in childhood 1988;63(12):1453-6.
1988: Benedetta C Sallustio; Y J Purdie; A G Whitehead; Michael J Ahern; P J Meffin
The disposition of ketoprofen enantiomers in man.
British journal of clinical pharmacology 1988;26(6):765-70.
1988: S G Kevat; W R Hill; P J McCarthy; Michael J Ahern
Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
Australian and New Zealand journal of medicine 1988;18(5):697-700.
1988: M G Cohen; S Kevat; M V Prowse; Michael J Ahern
Two distinct quinidine-induced rheumatic syndromes.
Annals of internal medicine 1988;108(3):369-71.
1988: Malcolm D Smith; A Smith; M Fehr; Michael J Ahern; Peter J Roberts-Thomson
Effects of chrysotherapy on circulating lymphocyte numbers and subsets.
Annals of the rheumatic diseases 1988;47(1):15-7.
1987: Michael J Ahern; C Reid; T P Gordon; M McCredie; P M Brooks; M Jones
Does colchicine work? The results of the first controlled study in acute gout.
Australian and New Zealand journal of medicine 1987;17(3):301-4.
1986: Peter J Roberts-Thomson; T R Southwood; B W Moore; Malcolm D Smith; Michael J Ahern; R A Geddes; W R Hill
Adult onset Still's disease or coxsackie polyarthritis?
Australian and New Zealand journal of medicine 1986;16(4):509-11.